| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |